更新された供給不足状況を示しています。
ある時点での供給不足の全体的状況は「供給関連情報」に定期的にアップします。
米国
- 2025.05.26
- 2025.05.26
New
May 23, 2025
- Minocycline Hydrochloride Capsule (Discontinuation)
- Nortriptyline Hydrochloride Capsule (Discontinuation)
May 19, 2025
- Potassium Chloride Capsule, Extended Release (Discontinuation)
Updated
May 23, 2025
- Mefloquine Hydrochloride Tablet (Currently In Shortage)
May 22, 2025
- Dextrose Monohydrate 5% Injection (Currently In Shortage)
- Midazolam Hydrochloride Injection (Currently In Shortage)
- Sodium Chloride 0.9% Injection (Currently In Shortage)
May 21, 2025
- Bupivacaine Hydrochloride Injection (Currently In Shortage)
- Lidocaine Hydrochloride Injection (Currently In Shortage)
- Methamphetamine Hydrochloride Tablet (Currently In Shortage)
- Rocuronium Bromide Injection (Currently In Shortage)
- Ropivacaine Hydrochloride Injection (Currently In Shortage)
May 20, 2025
- Amino Acid Injection (Currently In Shortage)
- Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet (Currently In Shortage)
- Azacitidine Injection (Currently In Shortage)
- Carboplatin Injection (Currently In Shortage)
- Dextrose Monohydrate 10% Injection (Currently In Shortage)
- Dextrose Monohydrate 5% Injection (Currently In Shortage)
- Hydromorphone Hydrochloride Injection (Currently In Shortage)
- Lactated Ringers Injection (Currently In Shortage)
- Lisdexamfetamine Dimesylate Capsule (Currently In Shortage)
- Methotrexate Sodium Injection (Currently In Shortage)
- Methylphenidate Hydrochloride Tablet, Extended Release (Currently In Shortage)
- Nitroglycerin Injection (Currently In Shortage)
- Oxazepam Capsule (Currently In Shortage)
- Sodium Chloride 0.9% Injection (Currently In Shortage)
- Sodium Chloride 0.9% Irrigation (Currently In Shortage)
- Sterile Water Irrigant (Currently In Shortage)
- Streptozocin Powder, For Solution (Currently In Shortage)
May 19, 2025
- Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet (Currently In Shortage)
- Lisdexamfetamine Dimesylate Capsule (Currently In Shortage)
- Lisdexamfetamine Dimesylate Tablet, Chewable (Currently In Shortage)
- Methylphenidate Film, Extended Release (Currently In Shortage)
- Methylphenidate Hydrochloride Tablet, Extended Release (Currently In Shortage)
- Naltrexone Hydrochloride Tablet (Currently In Shortage)
- Remifentanil Hydrochloride Injection (Currently In Shortage)
- Technetium TC-99M Pyrophosphate Kit Injection (Currently In Shortage)
- 2025.05.19
- 2025.05.19
New
May 14, 2025
- Cholestyramine Powder (Discontinuation)
- Oxybutynin Chloride Tablet (Discontinuation)
- Propafenone Hydrochloride Capsule, Extended Release (Discontinuation)
Updated
May 16, 2025
- Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet (Currently In Shortage)
- Methotrexate Sodium Injection (Currently In Shortage)
- Naltrexone Hydrochloride Tablet (Currently In Shortage)
May 15, 2025
- Indocyanine Green Injection (Currently In Shortage)
- Metronidazole Injection (Currently In Shortage)
- Peginterferon alfa-2a Injection (Currently In Shortage)
May 14, 2025
- Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection (Currently In Shortage)
- Carboplatin Injection (Currently In Shortage)
- Dextrose Monohydrate 5% Injection (Currently In Shortage)
- Fentanyl Citrate Injection (Currently In Shortage)
- Heparin Sodium Injection (Currently In Shortage)
- Hydromorphone Hydrochloride Injection (Currently In Shortage)
- Leucovorin Calcium Injection (Currently In Shortage)
- Lidocaine Hydrochloride Injection (Currently In Shortage)
- Morphine Sulfate Injection (Currently In Shortage)
- Propranolol Hydrochloride Injection (Currently In Shortage)
- Remifentanil Hydrochloride Injection (Currently In Shortage)
- Rocuronium Bromide Injection (Currently In Shortage)
- Sodium Chloride 0.9% Injection (Currently In Shortage)
- Sterile Water Injection (Currently In Shortage)
- Valproate Sodium Injection (Currently In Shortage)
May 12, 2025
- Promethazine Hydrochloride Injection (Currently In Shortage)
- 2025.05.12
- 2025.05.12
New
May 6, 2025
- Lisdexamfetamine Dimesylate Capsule (Currently In Shortage)
Updated
May 7, 2025
- Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet (Currently In Shortage)
- Azacitidine Injection (Currently In Shortage)
- Dexamethasone Sodium Phosphate Injection (Currently In Shortage)
- Hydromorphone Hydrochloride Injection (Currently In Shortage)
- Lisdexamfetamine Dimesylate Capsule (Currently In Shortage)
- Mefloquine Hydrochloride Tablet (Currently In Shortage)
- Methotrexate Sodium Injection (Currently In Shortage)
- Methylphenidate Hydrochloride Tablet, Extended Release (Currently In Shortage)
May 6, 2025
- Amino Acid Injection (Currently In Shortage)
- Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet (Currently In Shortage)
- Dextrose Monohydrate 10% Injection (Currently In Shortage)
- Dextrose Monohydrate 5% Injection (Currently In Shortage)
- Dextrose Monohydrate 70% Injection (Currently In Shortage)
- Etomidate Injection (Currently In Shortage)
- Midazolam Hydrochloride Injection (Currently In Shortage)
- Remifentanil Hydrochloride Injection (Currently In Shortage)
- Sodium Chloride 0.9% Injection (Currently In Shortage)
May 5, 2025
- Amino Acid Injection (Currently In Shortage)
- Dextrose Monohydrate 10% Injection (Currently In Shortage)
- Dextrose Monohydrate 5% Injection (Currently In Shortage)
- Dobutamine Hydrochloride Injection (Currently In Shortage)
- Heparin Sodium Injection (Currently In Shortage)
- Lactated Ringers Injection (Currently In Shortage)
- Lisdexamfetamine Dimesylate Capsule (Currently In Shortage)
- Lisdexamfetamine Dimesylate Tablet, Chewable (Currently In Shortage)
- Methylphenidate Hydrochloride Tablet, Extended Release (Currently In Shortage)
- Naltrexone Hydrochloride Tablet (Currently In Shortage)
- Nitroglycerin Injection (Currently In Shortage)
- Sodium Chloride 0.9% Irrigation (Currently In Shortage)
- Sterile Water Irrigant (Currently In Shortage)
- Technetium TC-99M Pyrophosphate Kit Injection (Currently In Shortage)
- 2025.05.05
- 2025.05.05
May 2, 2025
- Bumetanide Tablet (Discontinuation)
- Doxycycline Hyclate Tablet (Discontinuation)
- Drospirenone; Ethinyl Estradiol Tablet (Discontinuation)
April 29, 2025
- Heparin Sodium Injection (Discontinuation)
April 28, 2025
- Divalproex Sodium Tablet, Delayed Release (Discontinuation)
- Memantine Hydrochloride Tablet (Discontinuation)
- Midodrine Hydrochloride Tablet (Discontinuation)
- Nystatin Topical Powder (Discontinuation)
カナダ
カナダの情報はありません。
オーストラリア
- 2025.05.26
Active ingredients Dosage form Quantity of active ingredients Shortage status Availability Reason Last updated lorazepam Tablet, uncoated 1 mg Current Unavailable Manufacturing 23/05/2025 methylphenidate hydrochloride Tablet, modified release 27 mg Current Limited Availability Manufacturing 23/05/2025 oxycodone Suppository, compressed 30 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 23/05/2025 methylphenidate hydrochloride Capsule, modified release 10 mg Current Limited Availability Manufacturing 23/05/2025 sulfamethoxazole~trimethoprim Tablet, uncoated 800 mg~160 mg Current Limited Availability Manufacturing 23/05/2025 lansoprazole Tablet, orally disintegrating 15 mg Current Limited Availability Manufacturing 23/05/2025 metformin hydrochloride Tablet, film coated 1000 mg Current Unavailable Manufacturing 23/05/2025 methylphenidate hydrochloride Capsule, modified release 60 mg Current Limited Availability Manufacturing 23/05/2025 hydrocortisone Tablet, uncoated 20 mg Current Unavailable Manufacturing 23/05/2025 hydrocortisone Tablet, uncoated 20 mg Current Unavailable Manufacturing 23/05/2025 metoprolol tartrate Tablet, uncoated 50 mg Current Limited Availability Manufacturing 23/05/2025 methylphenidate hydrochloride Capsule, hard 40 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 23/05/2025 methylphenidate hydrochloride Capsule, hard 20 mg Anticipated Available Unexpected increase in demand due to other sponsors unable to supply 23/05/2025 methylphenidate hydrochloride Capsule, hard 30 mg Anticipated Available Unexpected increase in demand due to other sponsors unable to supply 23/05/2025 methylphenidate hydrochloride Capsule, hard 10 mg Anticipated Available Unexpected increase in demand due to other sponsors unable to supply 23/05/2025 methylphenidate hydrochloride Capsule, hard 60 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 23/05/2025 methylphenidate hydrochloride Tablet, modified release 54 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 23/05/2025 methylphenidate hydrochloride Tablet, modified release 36 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 23/05/2025 methylphenidate hydrochloride Tablet, modified release 27 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 23/05/2025 methylphenidate hydrochloride Tablet, modified release 18 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 23/05/2025 spironolactone Tablet, uncoated 25 mg Current Unavailable Manufacturing 23/05/2025 imipramine hydrochloride Tablet, sugar coated 25 mg Current Unavailable Manufacturing 23/05/2025 gemfibrozil Tablet, film coated 600 mg Current Unavailable Manufacturing 23/05/2025 reboxetine mesilate Tablet, uncoated 5.224 mg Current Unavailable Manufacturing 23/05/2025 methylphenidate hydrochloride Capsule, modified release 20 mg Anticipated Available Manufacturing 23/05/2025 methylphenidate hydrochloride Capsule, modified release 30 mg Anticipated Available Manufacturing 23/05/2025 methylphenidate hydrochloride Capsule, modified release 40 mg Current Limited Availability Manufacturing 23/05/2025 methylphenidate hydrochloride Tablet, modified release 18 mg Current Limited Availability Manufacturing 23/05/2025 methylphenidate hydrochloride Tablet, modified release 36 mg Current Limited Availability Manufacturing 23/05/2025 methylphenidate hydrochloride Tablet, modified release 54 mg Current Limited Availability Manufacturing 23/05/2025 adrenaline (epinephrine) acid tartrate Injection, solution 182 microgram/mL Resolved Available Manufacturing 22/05/2025 leuprorelin acetate~bicalutamide Injection, modified release~Tablet, film coated 22.5 mg~50 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 22/05/2025 bicalutamide~leuprorelin acetate Injection, modified release~Tablet, film coated 50 mg~7.5 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 22/05/2025 bicalutamide~leuprorelin acetate Injection, modified release~Tablet, film coated 50 mg~22.5 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 22/05/2025 hydromorphone hydrochloride Injection, solution 2 mg/mL Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 22/05/2025 hydromorphone hydrochloride Injection, solution 10 mg/mL Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 22/05/2025 ceftazidime pentahydrate~avibactam sodium Injection, powder for 2329.7 mg~543.5 mg Current Limited Availability Unexpected increase in consumer demand 22/05/2025 foscarnet sodium Injection, solution 24 mg/mL Current Limited Availability Manufacturing 22/05/2025 daptomycin Injection, powder for 500 mg Current Limited Availability Manufacturing 22/05/2025 betiatide Injection, powder for 1 mg Current Unavailable Manufacturing 21/05/2025 fludarabine phosphate Injection, powder for 50 mg Current Unavailable Manufacturing 21/05/2025 mesalazine Tablet, enteric coated 800 mg Anticipated Available Manufacturing 21/05/2025 Peginterferon alfa2a Injection, solution 135 microgram Anticipated Available Unexpected increase in consumer demand 21/05/2025 Peginterferon alfa2a Injection, solution 180 microgram Current Unavailable Unexpected increase in consumer demand 21/05/2025 gabapentin Capsule, hard 300 mg Current Limited Availability Manufacturing 20/05/2025 clonazepam Oral Liquid, solution 2.5 mg/mL Resolved Available Manufacturing 20/05/2025 methotrexate Tablet, uncoated 2.5 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 20/05/2025 ezetimibe~simvastatin Tablet 10 mg~20 mg Anticipated Available Manufacturing 20/05/2025 neostigmine methylsulfate Injection, solution 2.5 mg Current Unavailable Manufacturing 20/05/2025 rifampicin Capsule 300 mg Anticipated Available Manufacturing 20/05/2025 esomeprazole Capsule, enteric 20 mg Current Limited Availability Manufacturing 20/05/2025 dexmedetomidine hydrochloride Injection, concentrated 118 microgram/mL Current Unavailable Manufacturing 20/05/2025 metformin hydrochloride Tablet, film coated 1000 mg Current Limited Availability Unexpected increase in consumer demand 20/05/2025 metformin hydrochloride Tablet, film coated 1000 mg Current Unavailable Manufacturing 20/05/2025 montelukast sodium Tablet, film coated 10.4 mg Current Unavailable Manufacturing 20/05/2025 finasteride Tablet, film coated 1 mg Anticipated Available Manufacturing 20/05/2025 naproxen Tablet 500 mg Resolved Available Manufacturing 20/05/2025 estradiol hemihydrate Drug delivery system, transdermal 1.54 mg Resolved Available Unexpected increase in demand due to other sponsors unable to supply 20/05/2025 metformin hydrochloride Tablet, film coated 1000 mg Current Unavailable Manufacturing 20/05/2025 metformin hydrochloride Tablet, film coated 1000 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 20/05/2025 metformin hydrochloride Tablet, film coated 1000 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 20/05/2025 primidone Tablet, uncoated 250 mg Resolved Available Manufacturing 19/05/2025 alendronate sodium trihydrate Tablet, uncoated 91.35 mg Resolved Available Manufacturing 19/05/2025 isosorbide dinitrate Tablet, uncoated 5 mg Resolved Available Manufacturing 19/05/2025 trihexyphenidyl hydrochloride Tablet, uncoated 5 mg Resolved Available Unexpected increase in consumer demand 19/05/2025 carbidopa monohydrate~entacapone~levodopa Tablet, film coated 54 mg~200 mg~200 mg Anticipated Available Manufacturing 19/05/2025 levodopa~carbidopa monohydrate~entacapone Tablet, film coated 150 mg~40.5 mg~200 mg Anticipated Available Manufacturing 19/05/2025 atropine sulfate monohydrate Eye Drops, solution 9.9737 mg/mL Resolved Available Manufacturing 19/05/2025 salmeterol xinafoate~fluticasone propionate Inhalation, powder for 72.5 microgram/actuation~250 microgram/actuation Anticipated Available Manufacturing 19/05/2025 simvastatin Tablet, film coated 80 mg Resolved Available Manufacturing 19/05/2025 lacosamide Tablet, film coated 200 mg Current Unavailable Manufacturing 19/05/2025 lacosamide Tablet, film coated 100 mg Current Unavailable Manufacturing 19/05/2025 mupirocin calcium Ointment 21.5 mg/g Anticipated Available Manufacturing 19/05/2025 nitrofurantoin Capsule, hard 100 mg Current Limited Availability Manufacturing 19/05/2025 spironolactone Tablet, film coated 100 mg Current Unavailable Manufacturing 19/05/2025 - 2025.05.19
Active ingredients Dosage form Quantity of active ingredients Shortage status Availability Reason Last updated fentanyl Drug delivery system, transdermal 4.2 mg Discontinued Unavailable Manufacturing 16/05/2025 fentanyl Drug delivery system, transdermal 8.4 mg Discontinued Unavailable Manufacturing 16/05/2025 fentanyl Drug delivery system, transdermal 12.6 mg Discontinued Unavailable Manufacturing 16/05/2025 fentanyl Drug delivery system, transdermal 16.8 mg Discontinued Unavailable Manufacturing 16/05/2025 fentanyl Drug delivery system, transdermal 2.1 mg Discontinued Unavailable Manufacturing 16/05/2025 calcitonin salmon Injection, solution 100 IU/mL Current Limited Availability Commercial Changes / Commercial viability 16/05/2025 furosemide Injection, solution 20 mg Resolved Available Manufacturing 16/05/2025 silver sulfadiazine Cream 10 mg/g Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 16/05/2025 silver sulfadiazine Cream 10 mg/g Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 16/05/2025 fentanyl Drug delivery system, transdermal 5.1 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 16/05/2025 fentanyl Drug delivery system, transdermal 7.65 mg Discontinued Unavailable Commercial Changes / Commercial viability 16/05/2025 fentanyl Drug delivery system, transdermal 1.28 mg Discontinued Unavailable Commercial Changes / Commercial viability 16/05/2025 fentanyl Drug delivery system, transdermal 10.2 mg Discontinued Unavailable Commercial Changes / Commercial viability 16/05/2025 fentanyl Drug delivery system, transdermal 2.55 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 16/05/2025 carboplatin Injection, solution 450 mg Anticipated Available Manufacturing 16/05/2025 dulaglutide Injection, solution 1.5 mg Current Limited Availability Manufacturing 16/05/2025 busulfan Injection, concentrated 60 mg Current Limited Availability Manufacturing 16/05/2025 isavuconazonium sulfate Capsule, hard 186.3 mg Resolved Available Manufacturing 16/05/2025 buprenorphine hydrochloride Tablet, uncoated .216 mg Anticipated Available Manufacturing 16/05/2025 lidocaine hydrochloride Injection, solution 10 mg/mL Current Unavailable Manufacturing 16/05/2025 paclitaxel Injection, concentrated 6 mg/mL Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 16/05/2025 iopromide Injection, solution 498.72 mg/mL Resolved Available Manufacturing 16/05/2025 voriconazole Tablet, film coated 50 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 16/05/2025 sertraline hydrochloride Tablet, film coated 112 mg Anticipated Available Manufacturing 16/05/2025 ceftazidime pentahydrate Injection, powder for 2.328 g Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 15/05/2025 sumatriptan succinate Tablet, film coated 140 mg Resolved Available Manufacturing 15/05/2025 bethanechol chloride Tablet, uncoated 10 mg Anticipated Available Manufacturing 15/05/2025 galantamine hydrobromide Capsule, modified release 20.512 mg Current Limited Availability Manufacturing 15/05/2025 methylphenidate hydrochloride Capsule, modified release 10 mg Current Limited Availability Manufacturing 15/05/2025 valsartan~hydrochlorothiazide Tablet, film coated 160 mg~12.5 mg Current Limited Availability Manufacturing 15/05/2025 amlodipine besilate~atorvastatin calcium trihydrate Tablet, film coated 6.94 mg~43.376 mg Anticipated Available Manufacturing 15/05/2025 rosuvastatin calcium~ezetimibe Tablet~Tablet, film coated 10.396 mg~10 mg Resolved Available Manufacturing 15/05/2025 imatinib mesilate Capsule, hard 119.47 mg Resolved Available Manufacturing 15/05/2025 mercaptopurine monohydrate Tablet 50 mg Current Limited Availability Manufacturing 15/05/2025 topotecan hydrochloride Injection, concentrated 4.346 mg Resolved Available Manufacturing 15/05/2025 irinotecan hydrochloride trihydrate Injection, concentrated 500 mg Resolved Available Manufacturing 15/05/2025 metoprolol tartrate Tablet, uncoated 50 mg Current Limited Availability Manufacturing 15/05/2025 foscarnet sodium Injection, solution 24 mg/mL Current Limited Availability Manufacturing 15/05/2025 bleomycin sulfate Injection, powder for 15000 IU Anticipated Available Manufacturing 15/05/2025 trandolapril Capsule, hard 2 mg Anticipated Available Manufacturing 15/05/2025 losartan potassium Tablet, film coated 50 mg Current Limited Availability Unexpected increase in consumer demand 15/05/2025 voriconazole Injection, powder for 200 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 15/05/2025 sertraline hydrochloride Tablet, film coated 56 mg Anticipated Available Manufacturing 15/05/2025 Mumps virus~Rubella virus~Measles virus Injection, powder for 5000 CCID50~1000 CCID50~1000 CCID50 Anticipated Available Unexpected increase in consumer demand 15/05/2025 fentanyl Drug delivery system, transdermal 16.8 mg Resolved Available Unexpected increase in demand due to other sponsors unable to supply 14/05/2025 honey bee venom Injection, powder for 550 microgram Current Limited Availability Manufacturing 14/05/2025 perindopril erbumine Tablet 8 mg Current Limited Availability Manufacturing 14/05/2025 Paper wasp venom Injection, powder for 550 microgram Current Unavailable Manufacturing 14/05/2025 lansoprazole Tablet, orally disintegrating 15 mg Current Limited Availability Manufacturing 14/05/2025 celecoxib Capsule, hard 200 mg Current Limited Availability Manufacturing 14/05/2025 entecavir Tablet, film coated .5 mg Current Unavailable Manufacturing 14/05/2025 cisatracurium besilate Injection, solution 14.07 mg Current Limited Availability Manufacturing 14/05/2025 procarbazine hydrochloride Capsule, hard 58.3 mg Resolved Available Manufacturing 14/05/2025 atomoxetine hydrochloride Capsule, hard 91.44 mg Resolved Available Unexpected increase in demand due to other sponsors unable to supply 14/05/2025 olanzapine Tablet, uncoated 5 mg Resolved Available Manufacturing 14/05/2025 dosulepin hydrochloride Capsule, hard 25 mg Resolved Available Manufacturing 14/05/2025 methylphenidate hydrochloride Capsule, hard 40 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 14/05/2025 methylphenidate hydrochloride Capsule, hard 30 mg Anticipated Available Unexpected increase in demand due to other sponsors unable to supply 14/05/2025 methylphenidate hydrochloride Capsule, hard 10 mg Anticipated Available Unexpected increase in demand due to other sponsors unable to supply 14/05/2025 fentanyl citrate Injection, solution 785 microgram Current Limited Availability Manufacturing 14/05/2025 tamoxifen citrate Tablet, uncoated 15.2 mg Current Unavailable Manufacturing 14/05/2025 tamoxifen citrate Tablet, uncoated 30.4 mg Current Limited Availability Manufacturing 14/05/2025 gemfibrozil Tablet, film coated 600 mg Current Unavailable Manufacturing 14/05/2025 mirtazapine Tablet, film coated 30 mg Resolved Available Manufacturing 14/05/2025 trimethoprim~sulfamethoxazole Tablet 160 mg~800 mg Resolved Available Unexpected increase in consumer demand 13/05/2025 pramipexole dihydrochloride monohydrate Tablet .25 mg Anticipated Available Manufacturing 13/05/2025 phenobarbital sodium Injection, solution 219 mg/mL Anticipated Available Manufacturing 13/05/2025 galantamine hydrobromide Capsule, modified release 10.252 mg Current Unavailable Manufacturing 13/05/2025 galantamine hydrobromide Capsule, modified release 20.504 mg Current Unavailable Manufacturing 13/05/2025 ondansetron Tablet, orally disintegrating 8 mg Current Unavailable Manufacturing 13/05/2025 raloxifene hydrochloride Tablet, film coated 60 mg Resolved Available Unexpected increase in consumer demand 13/05/2025 dutasteride Capsule, soft 500 microgram Current Limited Availability Manufacturing 13/05/2025 capecitabine Tablet, film coated 500 mg Current Limited Availability Unexpected increase in consumer demand 13/05/2025 methotrexate Injection, solution 100 mg/mL Current Unavailable Manufacturing 13/05/2025 pramipexole dihydrochloride monohydrate Tablet, modified release .375 mg Current Limited Availability Manufacturing 13/05/2025 linezolid Tablet, film coated 600 mg Current Unavailable Manufacturing 13/05/2025 irbesartan Tablet, film coated 300 mg Anticipated Available Manufacturing 13/05/2025 irbesartan Tablet, film coated 150 mg Anticipated Available Manufacturing 13/05/2025 nizatidine Capsule, hard 150 mg Current Unavailable Manufacturing 13/05/2025 moxonidine Tablet, film coated 200 microgram Current Limited Availability Manufacturing 13/05/2025 ropinirole hydrochloride Tablet, film coated .57 mg Resolved Available Manufacturing 13/05/2025 risperidone Tablet, film coated 3 mg Resolved Available Transport / Logistic issues / Storage capacity issues 13/05/2025 atorvastatin calcium trihydrate~ezetimibe Tablet, film coated 41.363 mg~10 mg Current Unavailable Manufacturing 13/05/2025 suxamethonium chloride dihydrate Injection, solution 100 mg Anticipated Available Manufacturing 13/05/2025 methotrexate Tablet 10 mg Resolved Available Manufacturing 13/05/2025 azithromycin dihydrate Tablet, film coated 524 mg Current Unavailable Unexpected increase in consumer demand 13/05/2025 rivaroxaban Tablet, film coated 20 mg Current Limited Availability Manufacturing 13/05/2025 metoclopramide hydrochloride monohydrate Injection, solution 10.54 mg Anticipated Available Unexpected increase in consumer demand 13/05/2025 midazolam Injection, solution 5 mg/mL Current Limited Availability Unexpected increase in consumer demand 13/05/2025 Teriparatide Injection, solution 250 microgram Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 13/05/2025 metformin hydrochloride Tablet, film coated 1000 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 13/05/2025 Peginterferon alfa2a Injection, solution 180 microgram Current Limited Availability Unexpected increase in consumer demand 13/05/2025 heparin sodium Injection, solution 5000 IU/mL Resolved Available Unexpected increase in consumer demand 12/05/2025 exemestane Tablet, film coated 25 mg Current Unavailable Manufacturing 12/05/2025 aripiprazole Tablet, uncoated 10 mg Current Limited Availability Manufacturing 12/05/2025 sulfamethoxazole~trimethoprim Tablet, uncoated 800 mg~160 mg Current Limited Availability Manufacturing 12/05/2025 montelukast sodium Tablet, chewable 4.16 mg Anticipated Available Manufacturing 12/05/2025 quetiapine fumarate Tablet, modified release 57.565 mg Current Unavailable Unexpected increase in consumer demand 12/05/2025 zolmitriptan Tablet, film coated 2.5 mg Current Unavailable Manufacturing 12/05/2025 zolmitriptan Tablet, film coated 2.5 mg Current Unavailable Manufacturing 12/05/2025 adrenaline (epinephrine) acid tartrate Injection, solution 182 microgram/mL Current Unavailable Manufacturing 12/05/2025 estradiol~dydrogesterone Tablet, film coated 1 mg~10 mg Resolved Available Manufacturing 12/05/2025 ezetimibe Tablet, uncoated 10 mg Resolved Available Manufacturing 12/05/2025 olmesartan medoxomil~hydrochlorothiazide Tablet 40 mg~25 mg Resolved Available Manufacturing 12/05/2025 acamprosate calcium Tablet, enteric coated 333 mg Current Limited Availability Manufacturing 12/05/2025 avibactam sodium~ceftazidime pentahydrate Injection, powder for 543.5 mg~2329.7 mg Current Limited Availability Unexpected increase in consumer demand 12/05/2025 sitagliptin hydrochloride monohydrate Tablet, film coated 54.5 mg Resolved Available Manufacturing 12/05/2025 - 2025.05.12
Active ingredients Dosage form Quantity of active ingredients Shortage status Availability Reason Last updated olanzapine Tablet, orally disintegrating 5 mg Anticipated Available Manufacturing 9/05/2025 paclitaxel Injection, concentrated 300 mg Resolved Available Manufacturing 9/05/2025 hydrocortisone Tablet, uncoated 20 mg Current Limited Availability Manufacturing 9/05/2025 hydrocortisone Tablet, uncoated 20 mg Current Limited Availability Manufacturing 9/05/2025 spironolactone Tablet, uncoated 25 mg Current Limited Availability Manufacturing 9/05/2025 terbinafine hydrochloride Tablet, uncoated 281.25 mg Anticipated Available Manufacturing 8/05/2025 prazosin hydrochloride Tablet, uncoated 2.19 mg Anticipated Available Transport / Logistic issues / Storage capacity issues 8/05/2025 sumatriptan succinate Tablet, film coated 140 mg Current Unavailable Manufacturing 8/05/2025 risperidone Tablet, film coated 2 mg Current Unavailable Manufacturing 8/05/2025 midazolam Injection, solution 5 mg/mL Current Unavailable Manufacturing 8/05/2025 midazolam Injection, solution 1 mg/mL Current Limited Availability Manufacturing 8/05/2025 olanzapine Tablet, film coated 5 mg Anticipated Available Manufacturing 8/05/2025 gabapentin Tablet, film coated 800 mg Discontinued Unavailable Manufacturing 8/05/2025 galantamine hydrobromide Capsule, modified release 20.512 mg Anticipated Available Manufacturing 8/05/2025 midazolam Injection, solution 5 mg Current Limited Availability Manufacturing 8/05/2025 clopidogrel hydrogen sulfate Tablet, film coated 97.9 mg Current Limited Availability Manufacturing 8/05/2025 acetylcysteine Injection, concentrated 2 g Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 8/05/2025 lansoprazole Tablet, orally disintegrating 15 mg Current Limited Availability Manufacturing 8/05/2025 quetiapine fumarate Tablet, film coated 28.784 mg Current Limited Availability Unexpected increase in consumer demand 8/05/2025 simvastatin~ezetimibe Tablet 10 mg~10 mg Anticipated Available Manufacturing 8/05/2025 simvastatin~ezetimibe Tablet 20 mg~10 mg Anticipated Available Manufacturing 8/05/2025 celecoxib Capsule, hard 200 mg Current Limited Availability Manufacturing 8/05/2025 nicorandil Tablet 20 mg Anticipated Available Manufacturing 8/05/2025 nicorandil Tablet 10 mg Current Unavailable Manufacturing 8/05/2025 atomoxetine hydrochloride Capsule, hard 91.44 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 8/05/2025 noradrenaline (norepinephrine) acid tartrate monohydrate Injection, concentrated 2 mg/mL Resolved Available Transport / Logistic issues / Storage capacity issues 8/05/2025 dexmedetomidine hydrochloride Injection, concentrated 118 microgram/mL Current Unavailable Manufacturing 8/05/2025 dexmedetomidine hydrochloride Injection, intravenous infusion 118 microgram/mL Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 8/05/2025 escitalopram oxalate Tablet, film coated 12.74 mg Current Limited Availability Commercial Changes / Commercial viability 8/05/2025 solifenacin succinate Tablet, film coated 10 mg Current Unavailable Manufacturing 8/05/2025 codeine phosphate hemihydrate~ibuprofen Tablet, film coated 12.8 mg~200 mg Resolved Available Manufacturing 8/05/2025 emtricitabine~tenofovir disoproxil fumarate Tablet, film coated 200 mg~300 mg Resolved Available Manufacturing 8/05/2025 deferasirox Tablet, film coated 90 mg Anticipated Available Manufacturing 8/05/2025 atorvastatin calcium trihydrate Tablet, film coated 86.751 mg Current Limited Availability Manufacturing 8/05/2025 rivaroxaban Tablet, film coated 20 mg Current Unavailable Manufacturing 8/05/2025 spironolactone Tablet, uncoated 100 mg Current Limited Availability Manufacturing 8/05/2025 metoprolol tartrate Tablet, uncoated 50 mg Anticipated Available Manufacturing 8/05/2025 dutasteride~tamsulosin hydrochloride Capsule, modified release 500 microgram~400 microgram Resolved Available Manufacturing 8/05/2025 gemfibrozil Tablet, film coated 600 mg Current Unavailable Manufacturing 8/05/2025 primidone Tablet, uncoated 250 mg Current Unavailable Manufacturing 7/05/2025 bupivacaine hydrochloride monohydrate Injection, solution 52.7 mg Current Limited Availability Unexpected increase in consumer demand 7/05/2025 clopidogrel hydrogen sulfate Tablet, film coated 97.875 mg Resolved Available Unexpected increase in demand due to other sponsors unable to supply 7/05/2025 clopidogrel hydrogen sulfate Tablet, film coated 97.9 mg Current Unavailable Unexpected increase in consumer demand 7/05/2025 clopidogrel hydrogen sulfate Tablet, film coated 97.875 mg Current Limited Availability Unexpected increase in consumer demand 7/05/2025 ezetimibe~rosuvastatin calcium Tablet~Tablet, film coated 10 mg~10.396 mg Current Unavailable Manufacturing 7/05/2025 cisplatin Injection, solution 1 mg/mL Resolved Available Unexpected increase in demand due to other sponsors unable to supply 7/05/2025 erythromycin Capsule, enteric 250 mg Current Limited Availability Commercial Changes / Commercial viability 7/05/2025 spironolactone Tablet, film coated 25 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 7/05/2025 midazolam Injection, solution 1 mg/mL Current Limited Availability Unexpected increase in consumer demand 7/05/2025 fluorouracil Injection, solution 50 mg/mL Resolved Available Unexpected increase in demand due to other sponsors unable to supply 7/05/2025 clopidogrel hydrogen sulfate Tablet, film coated 97.875 mg Resolved Available Unexpected increase in demand due to other sponsors unable to supply 7/05/2025 betiatide Injection, powder for 1 mg Current Unavailable Manufacturing 6/05/2025 flecainide acetate Injection, solution 10 mg/mL Current Unavailable Manufacturing 6/05/2025 propofol Injection, emulsion 10 g/L Resolved Available Transport / Logistic issues / Storage capacity issues 6/05/2025 tramadol hydrochloride Tablet, modified release 200 mg Current Limited Availability Manufacturing 6/05/2025 carbidopa monohydrate~levodopa~entacapone Tablet, film coated 27 mg~100 mg~200 mg Anticipated Available Manufacturing 6/05/2025 rosuvastatin calcium~ezetimibe Tablet~Tablet, film coated 41.583 mg~10 mg Current Limited Availability Manufacturing 6/05/2025 Follitropin alfa Injection, solution 75 IU Resolved Available Manufacturing 6/05/2025 imatinib mesilate Tablet, film coated 119.5 mg Current Unavailable Unexpected increase in consumer demand 6/05/2025 cisplatin Injection, concentrated 1 mg/mL Resolved Available Manufacturing 6/05/2025 lacosamide Tablet, film coated 200 mg Current Limited Availability Manufacturing 6/05/2025 dimethyl fumarate Capsule, enteric 120 mg Current Unavailable Manufacturing 6/05/2025 lurasidone hydrochloride Tablet, film coated 80 mg Current Unavailable Manufacturing 6/05/2025 sitagliptin hydrochloride monohydrate Tablet, film coated 109 mg Resolved Available Manufacturing 6/05/2025 sitagliptin hydrochloride monohydrate Tablet, film coated 54.5 mg Current Unavailable Manufacturing 6/05/2025 levothyroxine sodium Tablet, uncoated .075 mg Current Limited Availability Manufacturing 6/05/2025 levothyroxine sodium Tablet, uncoated .1 mg Current Limited Availability Manufacturing 6/05/2025 rivaroxaban Tablet, film coated 2.5 mg Current Unavailable Unexpected increase in consumer demand 6/05/2025 rivaroxaban Tablet, film coated 10 mg Current Unavailable Unexpected increase in consumer demand 6/05/2025 sodium chloride Injection, intravenous infusion 900 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 6/05/2025 cabergoline Tablet, uncoated 1 mg Anticipated Available Manufacturing 6/05/2025 ciprofloxacin hydrochloride Tablet, film coated 873.32 mg Anticipated Available Manufacturing 6/05/2025 prazosin hydrochloride Tablet, uncoated 1.095 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 5/05/2025 trandolapril Capsule 4 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 5/05/2025 sodium pyrophosphate Injection, powder for 30 mg Current Unavailable Manufacturing 5/05/2025 fludarabine phosphate Injection, powder for 50 mg Anticipated Available Manufacturing 5/05/2025 octreotide Injection, solution 100 microgram Current Limited Availability Manufacturing 5/05/2025 octreotide Injection, solution 500 microgram Current Unavailable Manufacturing 5/05/2025 octreotide Injection, solution 50 microgram Current Limited Availability Manufacturing 5/05/2025 morphine hydrochloride trihydrate Oral Liquid, solution 10 mg/mL Resolved Available Commercial Changes / Commercial viability 5/05/2025 mycophenolate mofetil Capsule 250 mg Anticipated Available Manufacturing 5/05/2025 levetiracetam Tablet, film coated 500 mg Anticipated Available Manufacturing 5/05/2025 montelukast sodium Tablet, chewable 5.2 mg Anticipated Available Unexpected increase in consumer demand 5/05/2025 montelukast sodium Tablet, film coated 10.4 mg Anticipated Available Manufacturing 5/05/2025 montelukast sodium Tablet, chewable 4.16 mg Anticipated Available Manufacturing 5/05/2025 bicalutamide Tablet, film coated 50 mg Current Unavailable Manufacturing 5/05/2025 methotrexate Injection, solution 100 mg/mL Current Unavailable Manufacturing 5/05/2025 rifampicin Capsule 300 mg Anticipated Available Manufacturing 5/05/2025 amiodarone hydrochloride Injection, solution 150 mg Resolved Available Manufacturing 5/05/2025 live varicella vaccine Injection, powder for 4000 PFU/mL Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 5/05/2025 ezetimibe Tablet, uncoated 10 mg Current Unavailable Manufacturing 5/05/2025 acamprosate calcium Tablet, enteric coated 333 mg Current Limited Availability Manufacturing 5/05/2025 isavuconazonium sulfate Capsule, hard 186.3 mg Current Limited Availability Manufacturing 5/05/2025 midodrine hydrochloride Tablet 5 mg Anticipated Available Manufacturing 5/05/2025 naloxone hydrochloride dihydrate Spray, nasal 2.2 mg/actuation Resolved Available Transport / Logistic issues / Storage capacity issues 5/05/2025 nebivolol hydrochloride Tablet 10.9 mg Resolved Available Unexpected increase in demand due to other sponsors unable to supply 5/05/2025 prazosin hydrochloride Tablet, uncoated 1.1 mg Current Unavailable Manufacturing 5/05/2025 prazosin hydrochloride Tablet, uncoated 2.2 mg Current Unavailable Manufacturing 5/05/2025 reboxetine mesilate Tablet, uncoated 5.224 mg Current Unavailable Manufacturing 5/05/2025 - 2025.05.05
Active ingredients Dosage form Quantity of active ingredients Shortage status Availability Reason Last updated norethisterone Tablet, uncoated 350 microgram Resolved Available Unexpected increase in consumer demand 2/05/2025 lidocaine hydrochloride monohydrate~adrenaline (epinephrine) acid tartrate Injection, solution 21.3 mg/mL~22.7 microgram/mL Resolved Available Manufacturing 2/05/2025 sodium pertechnetate(99mTc) Injection, solution 18.5 GBq Current Unavailable Manufacturing 2/05/2025 fluconazole Injection, solution 2 mg/mL Discontinued Reduction in supply until supply is exhausted Manufacturing 2/05/2025 lamotrigine Tablet, chewable 100 mg Anticipated Available Manufacturing 2/05/2025 pramipexole dihydrochloride monohydrate Tablet 1 mg Current Unavailable Manufacturing 2/05/2025 pramipexole dihydrochloride monohydrate Tablet .25 mg Current Unavailable Transport / Logistic issues / Storage capacity issues 2/05/2025 metronidazole Tablet, uncoated 400 mg Current Limited Availability Manufacturing 2/05/2025 trimethoprim~sulfamethoxazole Tablet, uncoated 80 mg~400 mg Current Limited Availability Manufacturing 2/05/2025 finasteride Tablet, film coated 1 mg Anticipated Available Manufacturing 2/05/2025 isotretinoin Capsule, soft 10 mg Current Unavailable Manufacturing 2/05/2025 quetiapine fumarate Tablet, modified release 172.695 mg Current Limited Availability Unexpected increase in consumer demand 2/05/2025 oxytocin Injection, solution 10 IU/mL Current Limited Availability Manufacturing 2/05/2025 methylphenidate hydrochloride Capsule, modified release 60 mg Current Limited Availability Manufacturing 2/05/2025 calcipotriol~betamethasone dipropionate Ointment 52.2 microgram/g~643 microgram/g Current Unavailable Manufacturing 2/05/2025 imatinib mesilate Capsule, hard 119.47 mg Current Limited Availability Manufacturing 2/05/2025 tenofovir disoproxil maleate Tablet, film coated 300 mg Resolved Available Manufacturing 2/05/2025 dexmedetomidine hydrochloride Injection, concentrated 118 microgram/mL Current Unavailable Manufacturing 2/05/2025 busulfan Injection, concentrated 60 mg Current Limited Availability Manufacturing 2/05/2025 ezetimibe~atorvastatin calcium trihydrate Tablet, film coated 10 mg~82.725 mg Resolved Available Manufacturing 2/05/2025 dexmedetomidine hydrochloride Injection, concentrated 118 microgram/mL Current Limited Availability Manufacturing 2/05/2025 ropivacaine hydrochloride Injection, intravenous infusion 2 mg/mL Discontinued Unavailable Commercial Changes / Commercial viability 2/05/2025 atorvastatin calcium trihydrate Tablet, film coated 43.376 mg Current Limited Availability Manufacturing 2/05/2025 olanzapine Tablet, uncoated 5 mg Current Unavailable Manufacturing 2/05/2025 bortezomib Injection, solution 3.5 mg Current Limited Availability Manufacturing 2/05/2025 sitagliptin hydrochloride monohydrate~metformin hydrochloride Tablet, modified release 113.37 mg~1000 mg Current Unavailable Manufacturing 2/05/2025 metformin hydrochloride~sitagliptin hydrochloride monohydrate Tablet, modified release 1000 mg~56.685 mg Current Unavailable Manufacturing 2/05/2025 fluorouracil Cream 50 mg/g Current Unavailable Manufacturing 2/05/2025 rifampicin Capsule, hard 300 mg Resolved Available Manufacturing 2/05/2025 norethisterone~ethinylestradiol Tablet, uncoated 500 microgram~36 microgram Resolved Available Unexpected increase in consumer demand 2/05/2025 ethinylestradiol~norethisterone Tablet, uncoated 36 microgram~1 mg Resolved Available Manufacturing 2/05/2025 sodium pertechnetate(99mTc) Injection, solution 20 GBq Anticipated Available Manufacturing 2/05/2025 sodium pertechnetate(99mTc) Injection 370 GBq Anticipated Available Manufacturing 2/05/2025 iopromide Injection, solution 498.72 mg/mL Current Unavailable Manufacturing 2/05/2025 alprostadil Injection, powder for 20 microgram/mL Current Limited Availability Unexpected increase in consumer demand 2/05/2025 alprostadil Injection, powder for 40 microgram/mL Current Unavailable Manufacturing 2/05/2025 metformin hydrochloride Tablet, film coated 1000 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 2/05/2025 phenoxybenzamine hydrochloride Capsule, hard 10 mg Current Unavailable Manufacturing 1/05/2025 midazolam Injection, solution 5 mg Current Limited Availability Manufacturing 1/05/2025 letrozole Tablet, film coated 2.5 mg Current Limited Availability Manufacturing 1/05/2025 Choriogonadotropin alfa Injection, solution 250 microgram Current Limited Availability Unexpected increase in consumer demand 1/05/2025 perindopril erbumine Tablet 8 mg Current Limited Availability Manufacturing 1/05/2025 lansoprazole Tablet, orally disintegrating 15 mg Current Limited Availability Manufacturing 1/05/2025 rizatriptan benzoate Wafer 14.53 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 1/05/2025 esomeprazole Capsule, enteric 20 mg Current Limited Availability Manufacturing 1/05/2025 mercaptopurine monohydrate Tablet 50 mg Current Limited Availability Manufacturing 1/05/2025 timolol maleate~dorzolamide hydrochloride Eye Drops, solution 6.83 mg/mL~22.26 mg/mL Current Limited Availability Manufacturing 1/05/2025 metoprolol tartrate Tablet, uncoated 50 mg Anticipated Available Manufacturing 1/05/2025 valsartan~sacubitril Tablet, film coated 51.4 mg~48.6 mg Current Unavailable Manufacturing 1/05/2025 sacubitril~valsartan Tablet, film coated 24.3 mg~25.7 mg Current Unavailable Manufacturing 1/05/2025 valsartan~sacubitril Tablet, film coated 102.8 mg~97.2 mg Current Unavailable Manufacturing 1/05/2025 ropivacaine hydrochloride Injection, solution 2 mg/mL Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 1/05/2025 losartan potassium Tablet, film coated 50 mg Current Unavailable Unexpected increase in consumer demand 1/05/2025 spironolactone Tablet, film coated 100 mg Anticipated Available Manufacturing 1/05/2025 Tiger snake antivenom Injection, concentrated 3000 U Anticipated Available Manufacturing 1/05/2025 methylphenidate hydrochloride Capsule, modified release 10 mg Current Limited Availability Manufacturing 30/04/2025 amlodipine besilate~telmisartan Tablet, multilayer 6.935 mg~80 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 30/04/2025 telmisartan~amlodipine besilate Tablet, multilayer 40 mg~13.87 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 30/04/2025 telmisartan~amlodipine besilate Tablet, multilayer 40 mg~6.935 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 30/04/2025 telmisartan~amlodipine besilate Tablet, multilayer 80 mg~13.87 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 30/04/2025 rocuronium bromide Injection, solution 50 mg Resolved Available Manufacturing 30/04/2025 oxazepam Tablet, uncoated 15 mg Current Unavailable Manufacturing 30/04/2025 trandolapril Capsule, hard 1 mg Current Unavailable Manufacturing 30/04/2025 trandolapril Capsule, hard 2 mg Current Unavailable Manufacturing 30/04/2025 trandolapril Capsule, hard 4 mg Current Unavailable Manufacturing 30/04/2025 olmesartan medoxomil~hydrochlorothiazide~amlodipine besilate Tablet 40 mg~12.5 mg~6.944 mg Resolved Available Manufacturing 30/04/2025 telmisartan~amlodipine besilate Tablet, multilayer 40 mg~6.935 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 30/04/2025 amlodipine besilate~telmisartan Tablet, multilayer 13.87 mg~40 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 30/04/2025 telmisartan~amlodipine besilate Tablet, multilayer 80 mg~6.935 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 30/04/2025 telmisartan~amlodipine besilate Tablet, multilayer 80 mg~13.87 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 30/04/2025 capecitabine Tablet, film coated 500 mg Current Limited Availability Unexpected increase in consumer demand 30/04/2025 prilocaine hydrochloride~felypressin Injection, solution 30 mg/mL~.54 microgram/mL Resolved Available Manufacturing 30/04/2025 bosentan monohydrate Tablet, film coated 129.08 mg Resolved Available Transport / Logistic issues / Storage capacity issues 30/04/2025 methylphenidate hydrochloride Capsule, hard 40 mg Anticipated Available Unexpected increase in demand due to other sponsors unable to supply 30/04/2025 methylphenidate hydrochloride Capsule, hard 20 mg Anticipated Available Unexpected increase in demand due to other sponsors unable to supply 30/04/2025 methylphenidate hydrochloride Capsule, hard 30 mg Anticipated Available Unexpected increase in demand due to other sponsors unable to supply 30/04/2025 methylphenidate hydrochloride Capsule, hard 10 mg Anticipated Available Unexpected increase in demand due to other sponsors unable to supply 30/04/2025 methylphenidate hydrochloride Capsule, hard 60 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 30/04/2025 oxazepam Tablet, uncoated 30 mg Current Unavailable Manufacturing 30/04/2025 carboplatin Injection, solution 10 mg/mL Resolved Available Unexpected increase in demand due to other sponsors unable to supply 30/04/2025 midazolam Injection, solution 1 mg/mL Anticipated Available Unexpected increase in consumer demand 30/04/2025 methylphenidate hydrochloride Capsule, modified release 40 mg Current Limited Availability Manufacturing 30/04/2025 gentamicin Injection, solution 80 mg Resolved Available Manufacturing 29/04/2025 isosorbide dinitrate Tablet, uncoated 5 mg Anticipated Available Manufacturing 29/04/2025 donepezil hydrochloride Tablet, film coated 10 mg Resolved Available Manufacturing 29/04/2025 exemestane Tablet, film coated 25 mg Current Unavailable Manufacturing 29/04/2025 propofol Injection, emulsion 10 g/L Current Limited Availability Transport / Logistic issues / Storage capacity issues 29/04/2025 procarbazine hydrochloride Capsule, hard 58.3 mg Anticipated Available Manufacturing 29/04/2025 mupirocin Ointment 20 mg/g Current Limited Availability Unexpected increase in consumer demand 29/04/2025 metformin hydrochloride Tablet, film coated 1000 mg Current Limited Availability Unexpected increase in consumer demand 29/04/2025 atorvastatin calcium trihydrate~ezetimibe Tablet, film coated 20.681 mg~10 mg Current Unavailable Manufacturing 29/04/2025 ezetimibe~atorvastatin calcium trihydrate Tablet, film coated 10 mg~10.341 mg Current Unavailable Manufacturing 29/04/2025 deferasirox Tablet, film coated 90 mg Anticipated Available Manufacturing 29/04/2025 atorvastatin calcium trihydrate Tablet, film coated 10.844 mg Resolved Available Manufacturing 29/04/2025 atorvastatin calcium trihydrate Tablet, film coated 21.688 mg Resolved Available Manufacturing 29/04/2025 trimethoprim Tablet, uncoated 300 mg Current Limited Availability Manufacturing 29/04/2025 clopidogrel hydrogen sulfate Tablet, film coated 97.875 mg Current Unavailable Manufacturing 29/04/2025 naproxen Tablet, uncoated 250 mg Current Limited Availability Manufacturing 29/04/2025 dutasteride~tamsulosin hydrochloride Capsule, modified release 500 microgram~400 microgram Current Unavailable Manufacturing 29/04/2025 estradiol hemihydrate Drug delivery system, transdermal .77 mg Resolved Available Unexpected increase in demand due to other sponsors unable to supply 29/04/2025 estradiol hemihydrate Drug delivery system, transdermal 3.09 mg Resolved Available Unexpected increase in demand due to other sponsors unable to supply 29/04/2025 methylphenidate hydrochloride Tablet, uncoated 10 mg Resolved Available Transport / Logistic issues / Storage capacity issues 28/04/2025 valaciclovir Tablet, film coated 500 mg Current Limited Availability Manufacturing 28/04/2025 fentanyl Drug delivery system, transdermal 12.6 mg Resolved Available Manufacturing 28/04/2025 sulfamethoxazole~trimethoprim Tablet 800 mg~160 mg Current Limited Availability Unexpected increase in consumer demand 28/04/2025 sulfamethoxazole~trimethoprim Tablet, uncoated 800 mg~160 mg Current Limited Availability Manufacturing 28/04/2025 candesartan cilexetil Tablet, uncoated 4 mg Resolved Available Manufacturing 28/04/2025 carboplatin Injection, solution 450 mg Anticipated Available Manufacturing 28/04/2025 olmesartan medoxomil Tablet, film coated 40 mg Resolved Available Manufacturing 28/04/2025 solifenacin succinate Tablet, film coated 5 mg Current Unavailable Manufacturing 28/04/2025 solifenacin succinate Tablet, film coated 10 mg Current Unavailable Manufacturing 28/04/2025 lacosamide Tablet, film coated 100 mg Current Limited Availability Manufacturing 28/04/2025 pregabalin Capsule, hard 25 mg Resolved Available Manufacturing 28/04/2025 prasugrel Tablet, film coated 5 mg Resolved Available Manufacturing 28/04/2025 montelukast sodium Tablet, film coated 10.4 mg Current Limited Availability Manufacturing 28/04/2025 levothyroxine sodium Tablet .05 mg Resolved Available Manufacturing 28/04/2025 levothyroxine sodium Tablet .1 mg Current Limited Availability Manufacturing 28/04/2025 Fremanezumab Injection, solution 225 mg Current Limited Availability Unexpected increase in consumer demand 28/04/2025 reboxetine mesilate Tablet, uncoated 5.224 mg Anticipated Available Manufacturing 28/04/2025 methylphenidate hydrochloride Capsule, modified release 30 mg Anticipated Available Manufacturing 28/04/2025
ドイツ
- 2025.05.26
Active ingredients Message type Date of the last message Type of reason Arsenic(III) oxide Initial notification 23.05.2025 Production problem Ibandronate sodium monohydrate Change notification 23.05.2025 Other Fluphenazine decanoate Initial notification 23.05.2025 Production problem Fluphenazine decanoate Change notification 23.05.2025 Production problem Hydromorphone hydrochloride Change notification 23.05.2025 Other Moxifloxacin hydrochloride (Ph.Eur.) ((with details of water content (1:x))) Change notification 23.05.2025 Other Paliperidone palmitate Change notification 23.05.2025 Production problem Gentamicin sulphate Change notification 22.05.2025 Production problem Gentamicin sulphate Initial notification 22.05.2025 Production problem Insulin human ((with details of manufacture)) Initial notification 22.05.2025 Other Insulin aspart Change notification 22.05.2025 Other Insulin aspart Initial notification 22.05.2025 Other Betamethasone dipropionate (Ph.Eur.); salicylic acid Initial notification 22.05.2025 Other Betamethasone valerate (Ph.Eur.) Change notification 22.05.2025 Other Heparin sodium Initial notification 22.05.2025 Production problem Calcium acetate monohydrate Change notification 22.05.2025 Other Terazosin hydrochloride dihydrate Change notification 21.05.2025 Other Atorvastatin calcium trihydrate (Ph.Eur.) Change notification 21.05.2025 Other Tizanidine hydrochloride Initial notification 21.05.2025 Other Acemetacin Change notification 21.05.2025 Production problem Clomethiazole hemiedisilate Change notification 21.05.2025 Other Midazolam hydrochloride Initial notification 20.05.2025 Production problem Sodium (methylprednisolone-21-succinate) Initial notification 20.05.2025 Other Atenolol; chlorthalidone Change notification 20.05.2025 Other Methylphenidate hydrochloride Change notification 20.05.2025 Other Dacarbazine citrate Change notification 19.05.2025 Production problem Quetiapine fumarate (Ph.Eur.) Change notification 19.05.2025 Other Salbutamol sulfate Change notification 19.05.2025 Other Ipratropium bromide (Ph.Eur.) Change notification 19.05.2025 Production problem Quetiapine fumarate (Ph.Eur.) Change notification 19.05.2025 Other Cinacalcethydrochloride Change notification 19.05.2025 Other Carbamazepine Change notification 19.05.2025 Other Methylphenidate hydrochloride Change notification 19.05.2025 Other Pramipexole dihydrochloride monohydrate Change notification 19.05.2025 Other Quetiapine fumarate (Ph.Eur.) Change notification 19.05.2025 Other - 2025.05.19
Active ingredients Message type Date of the last message Type of reason Moxifloxacin hydrochloride (Ph.Eur.) ((with details of water content (1:x))) Initial notification 16.05.2025 Other Levomethadone hydrochloride Change notification 16.05.2025 Other Sodium mucophenolate Change notification 16.05.2025 Other Hydromorphone hydrochloride Change notification 16.05.2025 Other Arsenic(III) oxide Initial notification 16.05.2025 Other Sodium (methylprednisolone-21-succinate) Initial notification 16.05.2025 Other Moxifloxacin hydrochloride (Ph.Eur.) ((with details of water content (1:x))) Change notification 15.05.2025 Production problem Insulin aspart Initial notification 15.05.2025 Other Salbutamol sulfate Change notification 15.05.2025 Other Methylphenidate hydrochloride Change notification 15.05.2025 Other Aprepitant Change notification 15.05.2025 Other Quetiapine fumarate (Ph.Eur.) Change notification 15.05.2025 Other Sertraline hydrochloride Initial notification 15.05.2025 Production problem Flupentixol decanoate Change notification 15.05.2025 Production problem Aprepitant Initial notification 14.05.2025 Other Epinephrine/adrenaline Change notification 14.05.2025 Production problem Erythromycin Change notification 14.05.2025 Other Trazodone hydrochloride Initial notification 14.05.2025 Other Tenofovir disoproxil Change notification 14.05.2025 Other Ezetimibe; Simvastatin Initial notification 14.05.2025 Production problem Methylphenidate hydrochloride Initial notification 14.05.2025 Production problem Zoledronic acid monohydrate Change notification 14.05.2025 Production problem Cyclophosphamide monohydrate Change notification 14.05.2025 Other Zoledronic acid monohydrate Change notification 14.05.2025 Production problem Metformin hydrochloride; sitagliptin hydrochloride monohydrate Change notification 14.05.2025 Other Morphine hemisulfate 2,5-hydrate Initial notification 13.05.2025 Other Sodium (methylprednisolone-21-succinate) Initial notification 13.05.2025 Other Prednisolone Initial notification 13.05.2025 Production problem Lorazepam Initial notification 13.05.2025 Other Mometasone furoate (Ph.Eur.) Change notification 12.05.2025 Production problem Tropicamide Change notification 12.05.2025 Production problem Rizatriptan benzoate Change notification 12.05.2025 Production problem Ezetimibe Change notification 12.05.2025 Production problem Atomoxetine hydrochloride Change notification 12.05.2025 Production problem Cyclopentolate hydrochloride Change notification 12.05.2025 Production problem Atorvastatin calcium trihydrate (Ph.Eur.) Change notification 12.05.2025 Other Ciclopirox-Olamin Change notification 12.05.2025 Other Mometasone furoate (Ph.Eur.) Change notification 12.05.2025 Other - 2025.05.12
Active ingredients Message type Date of the last message Type of reason Atorvastatin calcium trihydrate (Ph.Eur.) Initial notification 09.05.2025 Other Clarithromycin Initial notification 09.05.2025 Production problem Tacrolimus Initial notification 09.05.2025 Other Trandolapril; verapamil hydrochloride Change notification 09.05.2025 Production problem Trandolapril; verapamil hydrochloride Change notification 09.05.2025 Other Tacrolimus monohydrate Change notification 09.05.2025 Production problem Sufentanil citrate Change notification 08.05.2025 Production problem Quetiapine fumarate (Ph.Eur.) Change notification 08.05.2025 Production problem Methylphenidate hydrochloride Change notification 08.05.2025 Other Mesalazine Initial notification 08.05.2025 Other Triptorelin acetate (1:x) ((with information on acetic acid content)) Initial notification 08.05.2025 Production problem Cabergoline Initial notification 07.05.2025 Other Fluorouracil Change notification 07.05.2025 Other Vincristine sulfate Initial notification 07.05.2025 Production problem Levetiracetam Change notification 07.05.2025 Production problem Atenolol; chlorthalidone Change notification 07.05.2025 Other Caspofungin diacetate Change notification 07.05.2025 Other Clobetasol propionate (Ph.Eur.) Initial notification 07.05.2025 Other Mometasone furoate (Ph.Eur.) Change notification 07.05.2025 Other Epirubicin hydrochloride Initial notification 07.05.2025 Production problem Doxorubicin hydrochloride Change notification 07.05.2025 Production problem Galantamine hydrobromide Change notification 06.05.2025 Production problem Atomoxetine hydrochloride Change notification 06.05.2025 Production problem Ethambutol dihydrochloride Initial notification 06.05.2025 Other Cinacalcethydrochloride Initial notification 06.05.2025 Other Iron(III) sodium D-gluconate hydroxide oxide complex (approx. 2:1:1:x:y) Initial notification 06.05.2025 Other Buprenorphine Change notification 06.05.2025 Other Azithromycin dihydrate Change notification 06.05.2025 Other Buprenorphine Change notification 06.05.2025 Other Articaine hydrochloride; epinephrine hydrogen tartrate/adrenaline hydrogen tartrate Change notification 05.05.2025 Production problem Mepivacaine hydrochloride Change notification 05.05.2025 Production problem Quetiapine fumarate (Ph.Eur.) Change notification 05.05.2025 Other Ciclosporin Initial notification 05.05.2025 Other Rotigotine Change notification 05.05.2025 Production problem Domperidone Change notification 05.05.2025 Production problem Melperone hydrochloride Change notification 05.05.2025 Production problem Gentamicin sulfate Change notification 05.05.2025 Production problem Vancomycin hydrochloride Change notification 05.05.2025 Other Ribavirin Initial notification 05.05.2025 Other Methylphenidate hydrochloride Change notification 05.05.2025 Other Indapamide Initial notification 05.05.2025 Production problem Benperidol Change notification 05.05.2025 Production problem Flupentixol decanoate Change notification 05.05.2025 Production problem Deferasirox Initial notification 05.05.2025 Other - 2025.05.05
Active ingredients Message type Date of the last message Type of reason Sertraline hydrochloride Change notification 02.05.2025 Other Doxorubicin hydrochloride Change notification 02.05.2025 Other Trimipramine mesilate Change notification 02.05.2025 Other Ampicillin sodium Change notification 02.05.2025 Production problem Quetiapine fumarate (Ph.Eur.) Change notification 02.05.2025 Production problem Linezolid Change notification 02.05.2025 Other Itraconazole Change notification 02.05.2025 Other Hydromorphone hydrochloride Change notification 02.05.2025 Other Atomoxetine hydrochloride Change notification 02.05.2025 Other Quetiapine fumarate (Ph.Eur.) Change notification 02.05.2025 Other Benperidol Initial notification 02.05.2025 Other Flupentixol decanoate Initial notification 02.05.2025 Other Cinacalcethydrochloride Change notification 02.05.2025 Other Fusidic acid (Ph.Eur.) Change notification 02.05.2025 Other Ciclopirox-Olamin Change notification 02.05.2025 Other Paliperidone palmitate Initial notification 30.04.2025 Other Pramipexole dihydrochloride monohydrate Initial notification 30.04.2025 Other Hydromorphone hydrochloride Change notification 30.04.2025 Other Insulin aspart Change notification 30.04.2025 Other Etoposide Change notification 30.04.2025 Other Sodium (methylprednisolone-21-succinate) Initial notification 29.04.2025 Other Tobramycin Change notification 29.04.2025 Production problem Azithromycin monohydrate Change notification 29.04.2025 Other Aprepitant Change notification 29.04.2025 Other Oxazepam Change notification 29.04.2025 Other Acemetacin Change notification 29.04.2025 Production problem Amoxicillin trihydrate Change notification 29.04.2025 Other Sodium (methylprednisolone-21-succinate) Change notification 29.04.2025 Other Iron(III) sodium D-gluconate hydroxide oxide complex (approx. 2:1:1:x:y) Change notification 29.04.2025 Other Salbutamol sulfate Initial notification 29.04.2025 Other Fluticasone propionate (Ph.Eur.) Change notification 29.04.2025 Other Methylprednisolone Initial notification 28.04.2025 Production problem Methylphenidate hydrochloride Change notification 28.04.2025 Production problem Phenoxymethylpenicillin potassium Change notification 28.04.2025 Other
フランス
- 2025.05.26
- 2025.05.19
Ingredients Status Update Specialty Immunoglobulin normal human (IgG) Supply tension 15/05/2025 Immunoglobulin normal human IV and SC (based on) – methylphenidate (hydrochloride) Available for use 15/05/2025 Methylphenidate Arrow LP, sustained-release capsule – disopyramide (phosphate) Out of stock 15/05/2025 Rythmodan 250 mg sustained-release, coated tablet – levodopa – carbidopa Available for use 15/05/2025 Sinemet 250 mg/25 mg, scored tablet – levomepromazine Available for use 15/05/2025 Nozinan 100 mg, scored film-coated tablet – peginterferon alfa-2a Supply tension 14/05/2025 Pegasys 90 micrograms, 135 micrograms and 180 micrograms solution for injection in pre-filled syringe – venlafaxine Supply tension 13/05/2025 Venlafaxine Viatris 50 mg, film-coated tablet – liothyronine sodium Supply tension 13/05/2025 Cynomel 0.025 mg, comprimé sécable- methylphenidate (hydrochloride) Out of stock 13/05/2025 Methylphenidate EG LP 18 mg and 54 mg, extended-release tablet – (tranexamic acid Supply tension 13/05/2025 Exacyl 500 mg, film-coated tablet – ) colchicine, opium (powder), tiemonium (metilsulfate) Supply tension 13/05/2025 Colchimax, scored film-coated tablet and Colchicine Opocalcium 1 mg, scored tablet – hydroxocobalamin Supply tension 12/05/2025 Cyanokit 5 g, powder for solution for infusion – amiodarone Supply tension 12/05/2025 Cordarone 150 mg/3 ml, solution for injection in ampoule (IV) – - 2025.05.12
Ingredients Status Update Specialty glucagon Supply tension 09/05/2025 Baqsimi 3 mg, nasal powder in unidose container – semaglutide (yeast/saccharomyces cerevisiae) Available for use 09/05/2025 Ozempic 0.25 mg, 0.5 mg, 1 mg, solution for injection in pre-filled pen – pregabalin Available for use 09/05/2025 Lyrica 20 mg/ml, oral solution – levomepromazine Supply tension 07/05/2025 Nozinan 100 mg, scored film-coated tablet – aciclovir Supply tension 07/05/2025 Zovirax 500 mg, powder for injectable solution (IV) – levodopa – carbidopa Available for use 07/05/2025 Levodopa Carbidopa Teva 100 mg/10 mg, scored tablet – travoprost Supply tension 07/05/2025 Travoprost 40 micrograms/mL, eye drops solution – amoxicillin sodium/potassium (clavulanate) Available for use 07/05/2025 Levmentin 1 g/200 mg, powder for solution for infusion (IV) – scopolamine Available for use 05/05/2025 Scopoderm TTS 1 mg/72 hours, transdermal device – diltiazem (hydrochloride) Supply tension 05/05/2025 Bi Tildiem L.P. 90 mg, sustained-release coated tablet – - 2025.05.05
Ingredients Status Update Specialty pyrantel (embonate) Out of stock 30/04/2025 Combantrin 125 mg, tablet – scopolamine Available again 30/04/2025 Scopoderm TTS 1 mg/72 hours, transdermal device – ondansetron Out of stock 30/04/2025 Zophren 4 mg/5 ml, syrup – evolocumab (mammalian/hamster/ cho cells) Supply tension 28/04/2025 Repatha 140 mg, solution for injection in pre-filled pen – gentamicin (sulfate of) Available again 28/04/2025 Gentamicin 40 mg, solution for injection 1 glass ampoule of 2 ml – levodopa – carbidopa Available again 28/04/2025 Levodopa Carbidopa Teva LP 100 mg/25 mg, extended-release tablet –
英国
- 2025.05.28
Discontinuation of Nystan® 100,000units/ml oral suspension (ready mixed) (Vygoris Ltd)
Pharmacy teams are advised that this brand has been discontinued and is no longer available for community pharmacies to order. Zydus Pharmaceuticals UK Ltd has introduced a generic version of Nystatin 100,000units/ml oral suspension, which is available to order from wholesalers. （当該ブランドの販売中止、Zydus Pharmaceuticals UK Ltdからジェネリックバージョンが導入）
Source: Community Pharmacy England
Medicine supply notification: Phenobarbital 15mg/5ml elixir
This is out of stock until late June 2025. Specials of phenobarbital 15mg/5ml oral solution and phenobarbital 15mg/5ml oral suspension remain available. A list of some Specials manufacturers who can source these unlicensed products is provided.（2025年6月下旬まで在庫切れ）
Source: Community Pharmacy England
Neurological disorders
- 2025.05.07
Medicine supply notification: Fentanyl (Effentora® ) 200 microgram, 400 microgram, 600 microgram, 800 microgram buccal tablets Fentanyl (Actiq® ) 800 microgram lozenges
These strengths of Effentora are out of stock until late May 2025.
Effentora 100 mcg remain available but cannot support increased demand.
Actiq 800 mcg out of stock with resupply date to be confirmed.
Other strengths of Actiq remain available but cannot support increased demand.Source: Community Pharmacy England
EU
EUの情報はありません。